Arkolith/Insider Trading/CAI/Form 4

Caris Halbert, L.P.

Director, 10% OwnerCaris Life Sciences, Inc. (CAI) · full profile →Form 4 · filed Jun 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Conversion(C)104.8M—$0121.0M
Jun 18, 2025Grant(A)414K—$02.4M
Mar 25, 2025Grant(A)361K—$02.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Conversion(C)29.6M——0
Jun 20, 2025Conversion(C)389.4M——0

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-061808) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML